Yuqin Liu1, Jinhua Zhang2. 1. Department of Health Care, The Forth People's Hospital of Jinan City Jinan 250031, China. 2. Department of Endocrinology, Binzhou City Central Hospital Binzhou 251700, China.
Abstract
PURPOSE: This study aimed to investigate the effect of Nox2 on cardiac fibrosis and to elucidate the regulatory mechanism of Nox2 in the development of DCM. METHODS: We established normal and insulin-resistant cellular model using neonatal rat cardiac fibroblasts. Then Nox2-specific siRNA were transfected into cardiac fibroblasts with Lipofectamine ® 2000 and crambled siRNA sequence was considered as control. Meanwhile, a part of cells were randomly selected to be treated with or without transforming growth factor-β (TGF-β). Moreover, quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were respectively performed to determine the expression level of related molecules, such as Nox2, collagen type I and III (COL I and III) and PI3K/AKT and PKC/Rho signaling pathway-related proteins. RESULTS: TGF-β stimulation significantly increased the expression level of Nox2 both in mRNA and protein levels. Suppression of the Nox2 markedly decreased the expression of COL I and COL III in normal and insulin-resistant cellular model with TGF-β stimulation. Moreover, suppression of the Nox2 significantly decreased the expression of PI3K/AKT and PKC/Rho signaling pathway-related proteins in insulin-resistant cellular model with TGF-β stimulation. However, suppression of Nox2 had no effects on these proteins without TGF-β stimulation. CONCLUSIONS: Our finding reveals that Nox2 may promote synthesis of COL I and III via involved in PI3K/AKT and PKC/Rho signaling pathway in a TGF-β dependent manner and consequently promote cardiac fibrosis in the development of DCM.
PURPOSE: This study aimed to investigate the effect of Nox2 on cardiac fibrosis and to elucidate the regulatory mechanism of Nox2 in the development of DCM. METHODS: We established normal and insulin-resistant cellular model using neonatal rat cardiac fibroblasts. Then Nox2-specific siRNA were transfected into cardiac fibroblasts with Lipofectamine ® 2000 and crambled siRNA sequence was considered as control. Meanwhile, a part of cells were randomly selected to be treated with or without transforming growth factor-β (TGF-β). Moreover, quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were respectively performed to determine the expression level of related molecules, such as Nox2, collagen type I and III (COL I and III) and PI3K/AKT and PKC/Rho signaling pathway-related proteins. RESULTS: TGF-β stimulation significantly increased the expression level of Nox2 both in mRNA and protein levels. Suppression of the Nox2 markedly decreased the expression of COL I and COL III in normal and insulin-resistant cellular model with TGF-β stimulation. Moreover, suppression of the Nox2 significantly decreased the expression of PI3K/AKT and PKC/Rho signaling pathway-related proteins in insulin-resistant cellular model with TGF-β stimulation. However, suppression of Nox2 had no effects on these proteins without TGF-β stimulation. CONCLUSIONS: Our finding reveals that Nox2 may promote synthesis of COL I and III via involved in PI3K/AKT and PKC/Rho signaling pathway in a TGF-β dependent manner and consequently promote cardiac fibrosis in the development of DCM.
Authors: Jennifer Martin; Darren J Kelly; Sally A Mifsud; Yuan Zhang; Alison J Cox; Fiona See; Henry Krum; Jennifer Wilkinson-Berka; Richard E Gilbert Journal: Cardiovasc Res Date: 2005-02-15 Impact factor: 10.787
Authors: H Ito; M Hiroe; Y Hirata; M Tsujino; S Adachi; M Shichiri; A Koike; A Nogami; F Marumo Journal: Circulation Date: 1993-05 Impact factor: 29.690
Authors: David J Grieve; Jonathan A Byrne; Anjana Siva; Joanne Layland; Sofian Johar; Alison C Cave; Ajay M Shah Journal: J Am Coll Cardiol Date: 2006-01-26 Impact factor: 24.094
Authors: PierMarco Piatti; Carlo Di Mario; Lucilla D Monti; Gabriele Fragasso; Fabio Sgura; Andrea Caumo; Emanuela Setola; Pietro Lucotti; Elena Galluccio; Cristina Ronchi; Anna Origgi; Ivana Zavaroni; Alberto Margonato; Antonio Colombo Journal: Circulation Date: 2003-10-06 Impact factor: 29.690
Authors: Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen Journal: Antioxid Redox Signal Date: 2019-11-01 Impact factor: 8.401